Humana, Centene file antitrust suit against Gilead for HIV drug agreements


The insurers referred to deals Gilead struck with Janssen, Bristol Myers Squibb to prevent the generic version of its retroviral medications from being used as part of combination treatments. They also allege the company struck a deal with Teva to delay the release of its generic drug.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.